201 related articles for article (PubMed ID: 30465671)
1. Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn.
Lothian A; Lago L; Mukherjee S; Connor AR; Fowler C; McLean CA; Horne M; Masters CL; Cappai R; Roberts BR
Metallomics; 2019 Jan; 11(1):128-140. PubMed ID: 30465671
[TBL] [Abstract][Full Text] [Related]
2. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Paik SR; Shin HJ; Lee JH
Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
[TBL] [Abstract][Full Text] [Related]
3. Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2.
Lee EN; Lee SY; Lee D; Kim J; Paik SR
J Neurochem; 2003 Mar; 84(5):1128-42. PubMed ID: 12603836
[TBL] [Abstract][Full Text] [Related]
4. Molecular understanding of copper and iron interaction with alpha-synuclein by fluorescence analysis.
Bharathi ; Rao KS
J Mol Neurosci; 2008 Jul; 35(3):273-81. PubMed ID: 18491043
[TBL] [Abstract][Full Text] [Related]
5. Effects of alpha-synuclein post-translational modifications on metal binding.
González N; Arcos-López T; König A; Quintanar L; Menacho Márquez M; Outeiro TF; Fernández CO
J Neurochem; 2019 Sep; 150(5):507-521. PubMed ID: 31099098
[TBL] [Abstract][Full Text] [Related]
6. The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease.
Al-Hilaly YK; Biasetti L; Blakeman BJ; Pollack SJ; Zibaee S; Abdul-Sada A; Thorpe JR; Xue WF; Serpell LC
Sci Rep; 2016 Dec; 6():39171. PubMed ID: 27982082
[TBL] [Abstract][Full Text] [Related]
7. Emerging Approaches to Investigate the Influence of Transition Metals in the Proteinopathies.
Lermyte F; Everett J; Brooks J; Bellingeri F; Billimoria K; Sadler PJ; O'Connor PB; Telling ND; Collingwood JF
Cells; 2019 Oct; 8(10):. PubMed ID: 31658742
[TBL] [Abstract][Full Text] [Related]
8. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.
Wang X; Moualla D; Wright JA; Brown DR
J Neurochem; 2010 May; 113(3):704-14. PubMed ID: 20141569
[TBL] [Abstract][Full Text] [Related]
9. Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.
Jinsmaa Y; Sullivan P; Gross D; Cooney A; Sharabi Y; Goldstein DS
Neurosci Lett; 2014 May; 569():27-32. PubMed ID: 24670480
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.
Bartels T; Choi JG; Selkoe DJ
Nature; 2011 Aug; 477(7362):107-10. PubMed ID: 21841800
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
[TBL] [Abstract][Full Text] [Related]
12. Copper(II)-induced self-oligomerization of alpha-synuclein.
Paik SR; Shin HJ; Lee JH; Chang CS; Kim J
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
[TBL] [Abstract][Full Text] [Related]
13. Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
Cai Y; Lendel C; Österlund L; Kasrayan A; Lannfelt L; Ingelsson M; Nikolajeff F; Karlsson M; Bergström J
Biochem Biophys Res Commun; 2015 Aug; 464(1):336-41. PubMed ID: 26129771
[TBL] [Abstract][Full Text] [Related]
14. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.
Turnbull S; Tabner BJ; El-Agnaf OM; Moore S; Davies Y; Allsop D
Free Radic Biol Med; 2001 May; 30(10):1163-70. PubMed ID: 11369507
[TBL] [Abstract][Full Text] [Related]
15. Low molar excess of 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote oligomerization of alpha-synuclein through different pathways.
Almandoz-Gil L; Welander H; Ihse E; Khoonsari PE; Musunuri S; Lendel C; Sigvardson J; Karlsson M; Ingelsson M; Kultima K; Bergström J
Free Radic Biol Med; 2017 Sep; 110():421-431. PubMed ID: 28690195
[TBL] [Abstract][Full Text] [Related]
16. Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation.
Mason RJ; Paskins AR; Dalton CF; Smith DP
Biochemistry; 2016 Aug; 55(34):4737-41. PubMed ID: 27517125
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease.
Bharathi ; Rao KS
Biochem Biophys Res Commun; 2007 Jul; 359(1):115-20. PubMed ID: 17531952
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and Cu+/2+ can induce oligomerization of α-synuclein in the absence of oxygen: Two types of oligomerization mechanisms for α-synuclein and related cell toxicity studies.
Ha Y; Yang A; Lee S; Kim K; Liew H; Lee SH; Lee JE; Lee HI; Suh YH; Park HS; Churchill DG
J Neurosci Res; 2014 Mar; 92(3):359-68. PubMed ID: 24288134
[TBL] [Abstract][Full Text] [Related]
19. Early events in copper-ion catalyzed oxidation of α-synuclein.
Tiwari MK; Leinisch F; Sahin C; Møller IM; Otzen DE; Davies MJ; Bjerrum MJ
Free Radic Biol Med; 2018 Jun; 121():38-50. PubMed ID: 29689296
[TBL] [Abstract][Full Text] [Related]
20. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
